Logo image of PFE.DE

PFIZER INC (PFE.DE) Stock Fundamental Analysis

Europe - FRA:PFE - US7170811035 - Common Stock

20.3 EUR
-0.16 (-0.78%)
Last: 9/19/2025, 5:28:40 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PFE. PFE was compared to 49 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PFE while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on PFE.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PFE was profitable.
PFE had a positive operating cash flow in the past year.
PFE had positive earnings in each of the past 5 years.
In the past 5 years PFE always reported a positive cash flow from operatings.
PFE.DE Yearly Net Income VS EBIT VS OCF VS FCFPFE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

PFE's Return On Assets of 5.22% is in line compared to the rest of the industry. PFE outperforms 48.98% of its industry peers.
PFE has a Return On Equity of 12.12%. This is comparable to the rest of the industry: PFE outperforms 55.10% of its industry peers.
PFE has a Return On Invested Capital (7.61%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for PFE is significantly below the industry average of 15.25%.
Industry RankSector Rank
ROA 5.22%
ROE 12.12%
ROIC 7.61%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
PFE.DE Yearly ROA, ROE, ROICPFE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

PFE has a Profit Margin of 16.84%. This is in the better half of the industry: PFE outperforms 69.39% of its industry peers.
In the last couple of years the Profit Margin of PFE has declined.
With a decent Operating Margin value of 28.52%, PFE is doing good in the industry, outperforming 77.55% of the companies in the same industry.
In the last couple of years the Operating Margin of PFE has grown nicely.
Looking at the Gross Margin, with a value of 73.96%, PFE is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
PFE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 28.52%
PM (TTM) 16.84%
GM 73.96%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
PFE.DE Yearly Profit, Operating, Gross MarginsPFE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

PFE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, PFE has more shares outstanding
PFE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PFE has an improved debt to assets ratio.
PFE.DE Yearly Shares OutstandingPFE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
PFE.DE Yearly Total Debt VS Total AssetsPFE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

An Altman-Z score of 2.14 indicates that PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.14, PFE perfoms like the industry average, outperforming 46.94% of the companies in the same industry.
PFE has a debt to FCF ratio of 4.97. This is a neutral value as PFE would need 4.97 years to pay back of all of its debts.
PFE has a Debt to FCF ratio (4.97) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.65 indicates that PFE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, PFE is in line with its industry, outperforming 46.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.97
Altman-Z 2.14
ROIC/WACC0.85
WACC8.91%
PFE.DE Yearly LT Debt VS Equity VS FCFPFE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

PFE has a Current Ratio of 1.16. This is a normal value and indicates that PFE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, PFE is doing worse than 67.35% of the companies in the same industry.
A Quick Ratio of 0.85 indicates that PFE may have some problems paying its short term obligations.
PFE has a Quick ratio of 0.85. This is comparable to the rest of the industry: PFE outperforms 40.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.85
PFE.DE Yearly Current Assets VS Current LiabilitesPFE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

4

3. Growth

3.1 Past

PFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 151.11%, which is quite impressive.
The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
PFE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.54%.
Measured over the past years, PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%

3.2 Future

The Earnings Per Share is expected to decrease by -4.48% on average over the next years.
Based on estimates for the next years, PFE will show a decrease in Revenue. The Revenue will decrease by -2.85% on average per year.
EPS Next Y0.26%
EPS Next 2Y0.86%
EPS Next 3Y0.2%
EPS Next 5Y-4.48%
Revenue Next Year0.25%
Revenue Next 2Y-0.23%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PFE.DE Yearly Revenue VS EstimatesPFE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
PFE.DE Yearly EPS VS EstimatesPFE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.07, the valuation of PFE can be described as very cheap.
PFE's Price/Earnings ratio is rather cheap when compared to the industry. PFE is cheaper than 87.76% of the companies in the same industry.
PFE is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.58, the valuation of PFE can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PFE indicates a rather cheap valuation: PFE is cheaper than 87.76% of the companies listed in the same industry.
PFE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 7.07
Fwd PE 7.58
PFE.DE Price Earnings VS Forward Price EarningsPFE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PFE is valued cheaper than 83.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PFE is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.97
EV/EBITDA 6.98
PFE.DE Per share dataPFE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PFE does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)27.18
PEG (5Y)6.66
EPS Next 2Y0.86%
EPS Next 3Y0.2%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.92%, PFE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.04, PFE pays a better dividend. On top of this PFE pays more dividend than 100.00% of the companies listed in the same industry.
PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.92%

5.2 History

The dividend of PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years3
Div Non Decr Years3
PFE.DE Yearly Dividends per sharePFE.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

89.68% of the earnings are spent on dividend by PFE. This is not a sustainable payout ratio.
PFE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP89.68%
EPS Next 2Y0.86%
EPS Next 3Y0.2%
PFE.DE Yearly Income VS Free CF VS DividendPFE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
PFE.DE Dividend Payout.PFE.DE Dividend Payout, showing the Payout Ratio.PFE.DE Dividend Payout.PayoutRetained Earnings

PFIZER INC

FRA:PFE (9/19/2025, 5:28:40 PM)

20.3

-0.16 (-0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners67.51%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap115.42B
Analysts70.67
Price Target24.98 (23.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.92%
Yearly Dividend1.44
Dividend Growth(5Y)3.3%
DP89.68%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.18%
Min EPS beat(2)32.91%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)43.14%
Min EPS beat(4)32.52%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)56.64%
EPS beat(12)12
Avg EPS beat(12)44.11%
EPS beat(16)16
Avg EPS beat(16)37.53%
Revenue beat(2)1
Avg Revenue beat(2)2.3%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)6.96%
Revenue beat(4)3
Avg Revenue beat(4)5.79%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)5
Avg Revenue beat(8)3.23%
Revenue beat(12)8
Avg Revenue beat(12)3.35%
Revenue beat(16)11
Avg Revenue beat(16)3.45%
PT rev (1m)-1.98%
PT rev (3m)-2.9%
EPS NQ rev (1m)1.1%
EPS NQ rev (3m)-15.73%
EPS NY rev (1m)2.96%
EPS NY rev (3m)1.8%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.2%
Revenue NY rev (1m)1.05%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 7.07
Fwd PE 7.58
P/S 2.14
P/FCF 10.97
P/OCF 8.98
P/B 1.54
P/tB N/A
EV/EBITDA 6.98
EPS(TTM)2.87
EY14.14%
EPS(NY)2.68
Fwd EY13.19%
FCF(TTM)1.85
FCFY9.12%
OCF(TTM)2.26
OCFY11.13%
SpS9.5
BVpS13.2
TBVpS-4.91
PEG (NY)27.18
PEG (5Y)6.66
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 12.12%
ROCE 10.81%
ROIC 7.61%
ROICexc 8.26%
ROICexgc 38.29%
OM 28.52%
PM (TTM) 16.84%
GM 73.96%
FCFM 19.48%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
ROICexc(3y)11.54%
ROICexc(5y)11.73%
ROICexgc(3y)46.07%
ROICexgc(5y)42.74%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexcg growth 3Y-10.89%
ROICexcg growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score7
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.97
Debt/EBITDA 2.3
Cap/Depr 40.51%
Cap/Sales 4.31%
Interest Coverage 5.77
Cash Conversion 60.76%
Profit Quality 115.66%
Current Ratio 1.16
Quick Ratio 0.85
Altman-Z 2.14
F-Score7
WACC8.91%
ROIC/WACC0.85
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)151.11%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%30%
EPS Next Y0.26%
EPS Next 2Y0.86%
EPS Next 3Y0.2%
EPS Next 5Y-4.48%
Revenue 1Y (TTM)13.54%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%10.31%
Revenue Next Year0.25%
Revenue Next 2Y-0.23%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.85%
EBIT growth 1Y65.39%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year23.41%
EBIT Next 3Y6.93%
EBIT Next 5Y3.57%
FCF growth 1Y16.62%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y4.31%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%